GA NCORP

Doctors

Jennifer Yannucci MD

Low Country Cancer Care Associates, PC
www.lcccsav.com

Education & Training

Medical School: Indiana University School of Medicine, Indianapolis, Indiana

Internship: Vanderbilt University Medical Center, Nashville, Tennessee

Residency: Vanderbilt University Medical Center, Nashville, Tennessee

Fellowship: Beth Israel Deaconess Medical Center, Boston, Massachusetts

Specialty and Certification

Hematology / Board Certified

Clinical Trial Cancer Types

Adrenal Cancer, Bile Duct Cancer, Bladder Cancer, Bone Tumor, Brain Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Gallbladder Cancer, Gastrointestinal Stromal Tumor (GIST), Germ Cell Tumor, Gestational trophoblastic disease, Gynecologic Cancers, Head and Neck Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Melanoma, Mesothelioma, Neuroendocrine Tumor, Ovarian Cancer, Parathyroid Cancer, Penile Cancer, Retroperitoneal Tumors, Sarcoma, Small Bowel Cancer, Solid Tumor, Stomach/ Gastric Cancer, Testicular Cancer, Thyroid Cancer, Ureter Cancer, Urethral Cancer

Affliations

St. Joseph's/Candler

Active Clinical Trial Sites


Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler

225 Candler Drive
Savannah, GA 31405
912-819-5704 (p)
www.sjchs.org

driving directions

Clinical Trials

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Adrenal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bile Duct Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bladder Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bone Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Brain Tumor

Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity
Cancer Type: Breast Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Cervical Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Colon/Rectal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Esophogeal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gallbladder Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gastrointestinal Stromal Tumor (GIST)

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Germ Cell Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gestational trophoblastic disease

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gynecologic Cancers

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Head and Neck Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Liver Cancer / Hepatoblastoma

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Lung Cancer

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients with Advanced Melanoma
Cancer Type: Melanoma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Mesothelioma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Neuroendocrine Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Ovarian Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Parathyroid Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Penile Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Retroperitoneal Tumors

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Sarcoma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Small Bowel Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Solid Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Stomach/ Gastric Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Testicular Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Thyroid Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Unknown Primary

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Ureter Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Urethral Cancer
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org